Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 08/31/15
Due: 08/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach | NCT02943603 | Weijing Sun, MD, FACP | user2@example.com | None | 2017-01-31 | 2019-07-31 | 2020-07-31 | - | - | 2025-07-14 |
| Phase II Study of Irinotecan and Panitumumab | NCT00836277 | Weijing Sun, MD, FACP | user2@example.com | None | 2009-05-31 | 2015-08-31 | 2016-08-31 | - | - | 2025-07-14 |